RSC Advances · 2016 · 27 citations · 26 references
Pentacyclic TriterpenediolPharmaceutical ScienceNanotherapeuticsAnticancer PotentialPharmaceutical ChemistryPlga NanoparticlesNanomedicineMedicinal ChemistryAnti-cancer AgentRadiation OncologyBiochemistryTumor TargetingPharmacologyNatural SciencesDrug Delivery SystemsNano-drug DeliveryAnticancer LeadMedicineDrug Discovery
A novel pentacyclic triterpenediol (TPD), an anticancer lead from<italic>Boswellia serrata</italic>, was encapsulated into PLGA nanoparticles, leading to enhancement in anticancer potential in EAT bearing mice model.
26